aTyr Pharma | LIFE - Cost Of Sales


aTyr Pharma reported $1.31M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Ardelyx USD 4.81M 6.04M Mar/2026
aTyr Pharma USD 1.31M 2.04M Mar/2026
Biogen USD 945.1M 147.6M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Cipla INR 29.71B 3.4B Jun/2026
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.82M 1.71M Mar/2026
CSL USD 3.87B 2.08B Dec/2025
Curis USD 314K 9.96M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Grifols EUR 1.51B 184.45M Dec/2025
Lakefront Biotherapeutics EUR 4.8M 4.34M Mar/2026
Novartis USD 3.71B 251M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
United Therapeutics USD 99.5M 33.9M Jun/2026